mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.6 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |